TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Triprolidine And Pseudoephedrine Hydrochlorides, and what generic alternatives are available?
Triprolidine And Pseudoephedrine Hydrochlorides is a drug marketed by Kv Pharm and Cenci and is included in three NDAs.
The generic ingredient in TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES is codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride. There are nineteen drug master file entries for this compound. Additional details are available on the codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES?
- What are the global sales for TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES?
- What is Average Wholesale Price for TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES?
Summary for TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 6 |
Patent Applications: | 9 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES at DailyMed |
![TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES drug patent expirations Drug patent expirations by year for TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES](/p/graph/s/t/TRIPROLIDINE_AND_PSEUDOEPHEDRINE_HYDROCHLORIDES-patent-expirations.png)